VarCov Co’s Recursion Pharmaceuticals RXRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$449K Buy
108,713
+65,876
+154% +$223K 0.22% 158
2026
Q2
$157K Sell
42,837
-128,756
-75% -$429K 0.06% 345
2026
Q1
$527K Buy
171,593
+43,057
+33% +$166K 0.2% 194
2025
Q4
$526K Buy
+128,536
New +$637K 0.21% 165

Other funds holding RXRX

VarCov Co's RXRX Position: Q3 2026 in Review

VarCov Co increased its Recursion Pharmaceuticals (RXRX) stake by 154% in Q3 2026, buying an estimated $223K and bringing the position to 108,713 shares worth $449K. The position accounts for 0.22% of the portfolio, ranked #158.

VarCov Co first reported a position in RXRX in Q4 2025 and has held it in 4 quarters since. The position peaked at $527K in Q1 2026. 353 funds tracked by Wall St. Rank hold RXRX as of Q3 2026.

  • VarCov Co held 108,713 shares of Recursion Pharmaceuticals worth $449K as of Q3 2026.
  • VarCov Co bought 65,876 Recursion Pharmaceuticals shares in Q3 2026, an estimated $223K.
  • Recursion Pharmaceuticals made up 0.22% of VarCov Co's portfolio in Q3 2026, its #158 holding.
  • VarCov Co first reported a position in Recursion Pharmaceuticals in Q4 2025 and has held it in 4 quarters since.
  • VarCov Co's Recursion Pharmaceuticals position peaked at $527K in Q1 2026.
  • 353 funds tracked by Wall St. Rank held Recursion Pharmaceuticals as of Q3 2026.

Based on VarCov Co's 13F filing for Q3 2026, filed 16 Nov 2026.